Metrion Biosciences
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
First Floor Building 2 Granta Centre Gre...Phone Number
+44 1223919100Website
www.metrionbiosciences.comRevenue
$6.7 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Metrion Biosciences
Metrion Biosciences is a contract research organization (CRO) that specializes in high-quality preclinical drug discovery services, focusing on ion channel screening, cardiac safety, and neuroscience. Their offerings include high-throughput screening, GLP hERG testing, and integrated drug discovery services. Metrion aims to empower pharmaceutical research and development by providing expert advice, reliable data, and exceptional customer service. They cater to a diverse clientele, including biotech and pharmaceutical companies, by delivering tailored solutions for drug discovery challenges.Explore more
Metrion Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Metrion Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Metrion Biosciences is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Metrion Biosciences had a recent Job posting/layoffs
Earning: See what the market has to say on Metrion Biosciences recently announced quarterly report
Check if Metrion Biosciences has recently received funding, and reach out quickly before it becomes old news!
Metrion Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Metrion Biosciences launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Metrion Biosciences
Funding: Get notified immidiatlly once Metrion Biosciences has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Metrion Biosciences
Compare insights from companies similar to Metrion Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Metrion Biosciences
$6.7M
11-50
Private
$14.2M
2015
CM
Christopher MathesGeneral Manager (North America)
Company Profile Activity
Activity Insights
Metrion Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Metrion Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Metrion Biosciences.
Metrion Biosciences financials insights
Gather financial insights about Metrion Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Grant
$2.5M
2021
Series B
$3.7M
Unspecified
$3.7M
2023
Private Equity
$4.4M
Metrion Biosciences Tech Stack
A closer look at the technologies used by Metrion Biosciences
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Funding
New Hire
Executive Move
Metrion Biosciences News & Media
Metrion Biosciences appoints Lee Patterson as CEO
CAMBRIDGE, England--(BUSINESS WIRE)--Metrion Biosciences (“Metrion”), the specialist preclinical contract research organisation (CRO) and a leader in ion channel screening, today announced the appointment of Lee Patterson as its new CEO, effective from 2nd December 2024. An experienced life sciences and CRO executive, Lee will guide the Company as it seeks to execute an ambitious growth strategy, enhancing its specialist services and expanding further in key global markets. He succeeds Dr AndreMetrion Biosciences Appoints Dr Chris Mathes as Chief Commercial Officer
CAMBRIDGE, England--(BUSINESS WIRE)--Metrion Biosciences Ltd (“Metrion”), the specialist preclinical contract research organisation (CRO) and a leader in ion channel screening, today announced the appointment of Dr Chris Mathes, MBA, as Chief Commercial Officer (CCO). Chris will work alongside the Company’s expert leadership team to drive commercial strategy and lead global business development and marketing activities. Following completion of Metrion’s £3.7M equity financing in December 20231,Metrion Biosciences Enhances High Throughput Screening Services With Access to Enamine Compound Libraries
CAMBRIDGE, England & KYIV, Ukraine--(BUSINESS WIRE)--Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organisation (CRO) and drug discovery company, and Enamine Ltd (“Enamine”), the global leader in supplying small molecules and early drug discovery services, announced that Metrion has enhanced its High Throughput Screening (HTS) services with the addition of access to Enamine’s compound libraries. The Enamine compound library coIon in the fire: Metrion Biosciences closes £3.7m Series B equity finance round
Board changes as company aims for more labs, equipment and global reach.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Metrion Biosciences
Sign Up For FreeTo access detailed company insights
Metrion Biosciences is a contract research organization (CRO) that specializes in high-quality preclinical drug discovery services, focusing on ion channel screening, cardiac safety, and neuroscience. Their offerings include high-throughput screening, GLP hERG testing, and integrated drug discovery services. Metrion aims to empower pharmaceutical r... Read More
